| Product Code: ETC10939543 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The vaccine import shipments to Cyprus in 2024 saw a significant increase in concentration, with Metropolitan France, Belgium, Denmark, UK, and USA emerging as the top exporting countries. The Herfindahl-Hirschman Index (HHI) indicated very high concentration levels, reflecting a competitive market. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 110.54%, with a notable growth rate of 52.24% from 2023 to 2024. This data suggests a robust expansion in the vaccine import market for Cyprus, driven by key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Vaccine Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Vaccine Market - Industry Life Cycle |
3.4 Cyprus Vaccine Market - Porter's Five Forces |
3.5 Cyprus Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cyprus Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Cyprus Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Cyprus Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Cyprus Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Cyprus Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Vaccine Market Trends |
6 Cyprus Vaccine Market, By Types |
6.1 Cyprus Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Cyprus Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Cyprus Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Cyprus Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Cyprus Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Cyprus Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Cyprus Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Cyprus Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Cyprus Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Cyprus Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Cyprus Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Cyprus Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Cyprus Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Cyprus Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Cyprus Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Cyprus Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Cyprus Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Cyprus Vaccine Market Import-Export Trade Statistics |
7.1 Cyprus Vaccine Market Export to Major Countries |
7.2 Cyprus Vaccine Market Imports from Major Countries |
8 Cyprus Vaccine Market Key Performance Indicators |
9 Cyprus Vaccine Market - Opportunity Assessment |
9.1 Cyprus Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cyprus Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Cyprus Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Cyprus Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Cyprus Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Cyprus Vaccine Market - Competitive Landscape |
10.1 Cyprus Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here